Colgate-Palmolive (India) Ltd
NSE:COLPAL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Colgate-Palmolive (India) Ltd
NSE:COLPAL
|
IN |
|
Context Therapeutics Inc
NASDAQ:CNTX
|
US |
|
S
|
Societe Generale SA
DUS:SGE
|
FR |
|
G
|
Grifols SA
SWB:OZTA
|
ES |
|
Capital Ltd
OTC:CAPFF
|
UK |
|
G
|
Gilead Sciences Inc
F:GIS
|
US |
|
N
|
NVIDIA Corp
SWB:NVD
|
US |
|
Strongpoint ASA
F:PGT
|
NO |
|
DoubleVerify Holdings Inc
NYSE:DV
|
US |
Wall St Price Targets
COLPAL Price Targets Summary
Colgate-Palmolive (India) Ltd
According to Wall Street analysts, the average 1-year price target for COLPAL is 2 241.96 INR with a low forecast of 1 818 INR and a high forecast of 2 940 INR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is COLPAL's stock price target?
Price Target
2 241.96
INR
According to Wall Street analysts, the average 1-year price target for COLPAL is 2 241.96 INR with a low forecast of 1 818 INR and a high forecast of 2 940 INR.
What is the Revenue forecast for Colgate-Palmolive (India) Ltd?
Projected CAGR
5%
Over the last 13 years, the compound annual growth rate for Revenue has been 6%. The projected CAGR for the next 3 years is 5%.
What is the Operating Income forecast for Colgate-Palmolive (India) Ltd?
Projected CAGR
5%
Over the last 13 years, the compound annual growth rate for Operating Income has been 10%. The projected CAGR for the next 3 years is 5%.
What is the Net Income forecast for Colgate-Palmolive (India) Ltd?
Projected CAGR
3%
Over the last 13 years, the compound annual growth rate for Net Income has been 9%. The projected CAGR for the next 3 years is 3%.
